Abstract
The large gains in knowledge of molecular biology have made it possible for pharmaceutical companies and researchers to make “designer” drugs and to target the drugs at specific disease points in the body rather than subjecting the entire organism to the effects of the drug. In this way, drugs may act much more efficiently.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Langer, R. (2003). Where a pill won’t reach. Scientific American, 288, 50–57.
Langer, R. (1998). Drug delivery and targeting. Nature, 392(Suppl), 5–10.
Langer, R. (1990). New methods of drug delivery. Science, 249, 1527–1533.
Torchilin, V. (2005). Recent advances with liposomes as pharmaceutical carriers. Nature Reviews in Drug Discovery, 4, 145–160.
Ratner, B.D., Hoffman, A.S., Schoen, F.J. & Lemons, J.E. et al. (Eds.). (2004). Drug delivery systems. In Biomaterials science: An introduction to materials in medicine. Elsevier: San Diego.
Gregoriadis, G. (Ed.). (2007). Liposome Technology 3rd edition, volumes I-III. Informa Healthcare: New York.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Baran, G.R., Kiani, M.F., Samuel, S.P. (2014). Clever Strategies for Controlled Drug Release and Targeted Drug Delivery. In: Healthcare and Biomedical Technology in the 21st Century. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8541-4_10
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8541-4_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8540-7
Online ISBN: 978-1-4614-8541-4
eBook Packages: EngineeringEngineering (R0)